Page last updated: 2024-08-17

galactose and 3-nitrotyrosine

galactose has been researched along with 3-nitrotyrosine in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (33.33)18.2507
2000's1 (33.33)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bou-Hanna, C; Jarry, A; Laboisse, CL; Le Goffe, C; Vallette, G1
Koppolu, P; Kowluru, RA1
Bao, D; Chen, Q; Cui, Y; Dai, Y; Fu, H; Hao, Q; Hou, D; Nie, X; Yan, Z; Yin, Y; Zheng, Y1

Other Studies

3 other study(ies) available for galactose and 3-nitrotyrosine

ArticleYear
The in vitro manipulation of carbohydrate metabolism: a new strategy for deciphering the cellular defence mechanisms against nitric oxide attack.
    The Biochemical journal, 1999, Dec-15, Volume: 344 Pt 3

    Topics: Adenosine Triphosphate; Carbohydrate Metabolism; Cell Survival; Culture Media; Deoxyglucose; Epithelial Cells; Galactose; Glucose; Glutathione; HT29 Cells; Humans; Lactic Acid; Nitric Oxide; Nitroso Compounds; Oligomycins; Pyruvic Acid; S-Nitrosoglutathione; Tyrosine

1999
Termination of experimental galactosemia in rats, and progression of retinal metabolic abnormalities.
    Investigative ophthalmology & visual science, 2002, Volume: 43, Issue:10

    Topics: Animals; Disease Progression; Drug Administration Schedule; Galactose; Galactosemias; Glutathione; Hexoses; Lipid Peroxides; Male; Metabolic Diseases; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Oxidative Stress; Protein Kinase C; Rats; Rats, Sprague-Dawley; Retina; Retinal Diseases; Tyrosine

2002
Curcumin exerts a protective effect against premature ovarian failure in mice.
    Journal of molecular endocrinology, 2018, Volume: 60, Issue:3

    Topics: 8-Hydroxy-2'-Deoxyguanosine; Aldehydes; Animals; Anti-Mullerian Hormone; Apoptosis; Curcumin; Cyclin-Dependent Kinase Inhibitor p16; Deoxyguanosine; Disease Models, Animal; Female; Galactose; Gonads; Hypothalamo-Hypophyseal System; Mice, Inbred C57BL; Ovary; Oxidative Stress; Primary Ovarian Insufficiency; Protective Agents; RNA, Messenger; Tyrosine

2018